Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 18.08 is in line with its 3-year average of 17.17, around the middle of its 3-year range (0.00–32.95).
As of the fiscal period ended Tuesday, June 30, 2026. 28.21% below its 12-month average of 25.19.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 18.08.
QUICK RATIO (ACID-TEST)
18.08
QUICK RATIO (ACID-TEST) AVG TTM
25.19
QUICK RATIO (ACID-TEST) AVG 3Y
18.49
QUICK RATIO (ACID-TEST) AVG 5Y
N/A
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
-28.21%
CURRENT VS 3Y AVG
-2.20%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
2.99
median of 608 covered companies
CURRENT VS SECTOR MEDIAN
+504.81%
vs the sector median at left
MBX Biosciences, Inc. Common Stock
Market Cap
$2.68B
Quick Ratio (Acid-Test)
18.08
TTM Avg
25.19
3Y Avg
18.49
5Y Avg
N/A
Market Cap
$2.68B
Quick Ratio (Acid-Test)
1.16
TTM Avg
1.32
3Y Avg
1.06
5Y Avg
0.97
Market Cap
$2.68B
Quick Ratio (Acid-Test)
1.56
TTM Avg
1.27
3Y Avg
1.12
5Y Avg
1.27
Market Cap
$2.71B
Quick Ratio (Acid-Test)
2.91
TTM Avg
2.57
3Y Avg
2.71
5Y Avg
4.41
Market Cap
$2.60B
Quick Ratio (Acid-Test)
14.57
TTM Avg
8.96
3Y Avg
7.17
5Y Avg
6.28
Market Cap
$2.58B
Quick Ratio (Acid-Test)
9.03
TTM Avg
7.98
3Y Avg
9.04
5Y Avg
8.34
Market Cap
$2.79B
Quick Ratio (Acid-Test)
6.07
TTM Avg
7.05
3Y Avg
8.10
5Y Avg
8.04
Market Cap
$2.82B
Quick Ratio (Acid-Test)
12.02
TTM Avg
18.93
3Y Avg
12.46
5Y Avg
15.83
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| MBX Biosciences, Inc. Common Stock (MBX) | $2.68B | 18.08 | 25.19 | 18.49 | N/A |
| Aveanna Healthcare Holdings Inc. (AVAH)vs › | $2.68B | 1.16 | 1.32 | 1.06 | 0.97 |
| Acadia Healthcare Company, Inc. (ACHC)vs › | $2.68B | 1.56 | 1.27 | 1.12 | 1.27 |
| Neogen Corporation (NEOG)vs › | $2.71B | 2.91 | 2.57 | 2.71 | 4.41 |
| Beam Therapeutics Inc. (BEAM)vs › | $2.60B | 14.57 | 8.96 | 7.17 | 6.28 |
| NewAmsterdam Pharma Company N.V. (NAMS)vs › | $2.58B | 9.03 | 7.98 | 9.04 | 8.34 |
| AtriCure, Inc. (ATRC)vs › | $2.78B | 3.19 | 2.81 | 2.79 | 3.25 |
| TransMedics Group, Inc. (TMDX)vs › | $2.79B | 6.07 | 7.05 | 8.10 | 8.04 |
| Dyne Therapeutics, Inc. (DYN)vs › | $2.82B | 12.02 | 18.93 | 12.46 | 15.83 |
| Alamar Biosciences, Inc. (ALMR)vs › | $2.41B | 10.23 | 3.96 | 3.96 | 3.96 |
Quick Ratio
18.08
Excludes inventory
Current Ratio
18.08
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 18.08 |
| 2026-03-31 | 30.79 |
| 2025-12-31 | 24.62 |
| 2025-09-30 | 32.95 |
| 2025-06-30 | 19.50 |
| 2025-03-31 | 23.31 |
| 2024-12-31 | 24.19 |
| 2024-09-30 | 25.75 |
| 2024-06-30 | 7.17 |
| 2024-03-31 | 12.76 |
| 2023-12-31 | 21.26 |
| 2023-09-30 | 0.00 |
| 2023-06-30 | 0.00 |
| 2023-03-31 | 0.00 |
